Feedback

X
Innovations in the Integrated Management of Breast Cancer

Innovations in the Integrated Management of Breast Cancer

0 Ungluers have Faved this Work
Breast cancer is acknowledged as an international priority in healthcare. It is currently the most common cancer in women worldwide, with demographic trends indicating a continuous increase in incidence. Over the years, increasing efforts and resources have been devoted to the search for a systematic and optimized strategy in breast cancer diagnosis and treatment. Today, the Breast Unit model is considered the gold standard in order to ensure optimal patient-centered and research-based clinical services through multidisciplinary and integrated management.Surgical treatment has gradually evolved toward less aggressive approaches with the adoption of new therapeutic strategies. The evolution of evidence-based guidelines in such leading disciplines as radiation and medical oncology has led to a steady improvement in survival rates. This Special Issue will highlight innovations in the integrated management of breast cancer, their potential advantages, and the many open issues that still need to be properly defined and addressed.

This book is included in DOAB.

Why read this book? Have your say.

You must be logged in to comment.

Rights Information

Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.

Downloads

This work has been downloaded 51 times via unglue.it ebook links.
  1. 51 - pdf (CC BY) at Unglue.it.

Keywords

  • acellular dermal matrix (ADM)
  • adjuvant treatment
  • advanced breast cancer
  • aesthetic and oncological outcomes
  • AMH
  • artificial intelligence
  • Breast cancer
  • breast cancer treatment
  • breast pathology
  • breast surgery
  • breast ultrasound
  • breast-conserving surgery
  • CDK4/6 inhibitor
  • CDK4/6 inhibitors
  • chemotherapy
  • Clinical Trial
  • conventional CT and CT angiography
  • DataMart
  • DIEP flap planning
  • ductal breast cancer
  • endocrine resistance
  • Evidence-based medicine
  • Frailty
  • gene profiling
  • Healthcare
  • Hepatic Surgery
  • Histology
  • hormone expression
  • hormone receptor
  • image-guided localization
  • immediate breast reconstruction
  • Immune system
  • in situ breast cancer
  • integrated therapies
  • large database
  • liver metastases
  • lobular breast cancer
  • locally advanced breast cancer
  • locoregional therapy
  • lung cancer
  • lymphatic microsurgery
  • lymphaticovenous anastomosis
  • lymphedema
  • Machine learning
  • medicine
  • metabolic derangements
  • metastatic breast cancer
  • mini-invasive treatment
  • miRNAs
  • mTOR inhibitor
  • multidisciplinary
  • Multidisciplinary treatment
  • n/a
  • neoadjuvant chemotherapy
  • networks
  • next-generation-sequencing
  • nipple-sparing mastectomy
  • non-palpable breast lesions
  • normal breast
  • Old age
  • older cancer patients
  • oligometastatic breast cancer
  • oncological outcomes
  • oncology
  • Oncotype Dx
  • osteoclast-like giant cells
  • Other branches of medicine
  • ovarian reserve
  • patient enrollment
  • patient quality of life
  • personalization
  • personalized medicine
  • personalized treatment
  • Pharmacology
  • physical performance
  • precision medicine
  • predictive model
  • Pregnancy
  • pregnancy desire
  • preoperative breast localization
  • Quality of life
  • Radiotherapy
  • rare breast cancer
  • real world data
  • Sarcopenia
  • sentinel lymph node
  • standardized data collection
  • subtypes breast cancer
  • Survival
  • systemic treatment
  • Tailoring
  • target therapy
  • vascularized lymph node transfer
  • Vitamin D
  • web app

Links

DOI: 10.3390/books978-3-0365-3801-3

Editions

edition cover

Share

Copy/paste this into your site: